Target intelligence / Profile preview

Histone H2A type 2-B (H2AC21)

Target
H2AC21
Molecular classification
Histone, Core histone, Nucleosome component, Chromatin-associated protein
01

Overview

Histone H2A type 2-B (H2AC21) is a core histone protein that, along with H2B, H3, and H4, forms the histone octamer around which DNA winds to create nucleosomes, the fundamental units of chromatin structure in eukaryotic nuclei[2][4]. H2A variants, including H2AC21, display significant sequence divergence in their terminal regions, which can influence nucleosome stability, DNA accessibility, and chromatin fiber formation[2]. These properties are essential for cellular processes including DNA replication, gene expression regulation, DNA repair, and higher-order chromatin dynamics[2][4]. Post-translational modifications of H2A (such as monoubiquitylation) can participate in DNA repair-induced chromatin remodeling[4]. While some histone variants (such as H2A.X) have a more direct role in genome stability and DNA repair, H2AC21 is primarily a component of the canonical histone pool in humans and is not itself a common drug target, receptor, or disease biomarker. Not a classic drug target or receptor; rather, H2AC21 is a protein component essential for fundamental chromatin structure and function[2][4]. Roles in health and disease are mostly indirect, via its influence on the epigenome. No drugs are known to directly or selectively target H2AC21. Not used as a biomarker in clinical practice.

Other names
H2A clustered histone 21H2AC21HIST2H2ABH2ABhistone H2A type 2-Bhistone cluster 2, H2A family member b
02

Mechanism of action

Not applicable (no direct therapeutics or drugs established for H2AC21)

03

Biological functions

DNA packagingChromatin structure maintenanceRegulation of gene expressionParticipation in DNA repairFacilitation of DNA replicationEpigenetic regulation
04

Disease associations

Other (Altered expression or post-translational modification patterns in cancer and genome instability)
05

Safety considerations

None specific for H2AC21 as a therapeutic targetoff-target effects on histone function can broadly disrupt genomic regulation

Beyond the preview

Go deeper on Histone H2A type 2-B (H2AC21).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Histone H2A type 2-B (H2AC21).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call